In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.

In the United States, more than 1,000 cases have been reported to the Centers for Disease Control and Prevention in 2025.